+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Shield Minimally Invasive Fascial Closure Device Market - Global Forecast to 2030- Product Image
Shield Minimally Invasive Fascial Closure Device Market - Global Forecast to 2030- Product Image
New

Shield Minimally Invasive Fascial Closure Device Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 195 Pages
  • May 2025
  • Region: Global, United States
  • 360iResearch™
  • ID: 6082007
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
Minimally invasive surgery has revolutionized patient care, driving demand for advanced fascial closure solutions that balance efficacy with safety. The Shield Minimally Invasive Fascial Closure Device exemplifies this evolution, offering surgeons enhanced precision and control during tissue approximation. By integrating ergonomic design with innovative materials, the device minimizes postoperative complications such as herniation and infection while accelerating recovery times. As healthcare systems strive to optimize operating room efficiency and patient outcomes, the Shield device addresses key challenges in fascia closure, from reducing incision size to streamlining suturing workflows. This introduction sets the stage for a comprehensive exploration of market dynamics, emerging shifts, regulatory pressures and strategic imperatives shaping the global fascial closure landscape.

Transformative Shifts Reshaping the Fascial Closure Landscape

The landscape of fascial closure is undergoing rapid transformation, propelled by technological breakthroughs, shifting patient expectations and regulatory evolution. Advanced imaging and robotic-assistance platforms are enabling surgeons to perform closures with submillimeter accuracy, while smart suture materials embedded with antimicrobial agents and bioactive coatings are entering clinical trials. Concurrently, value-based care models are pressuring providers to demonstrate cost-effectiveness, incentivizing the adoption of devices that reduce hospital stays and readmissions. In parallel, an aging population with complex comorbidities has increased demand for solutions tailored to geriatric and high-risk cohorts. Regulatory agencies worldwide are harmonizing safety and performance standards, accelerating product approvals but raising compliance demands. Finally, the convergence of data analytics with surgical quality registries is empowering continuous improvement in closure techniques. Together, these shifts underscore a pivotal moment: companies that harness innovation, demonstrate real-world value and navigate evolving regulations will define the next era of fascial closure.

Assessing the Cumulative Impact of U.S. Tariffs in 2025

Beginning in early 2025, the implementation of heightened U.S. tariffs on imported surgical devices has exerted a material influence on cost structures and sourcing strategies. Manufacturers reliant on overseas suppliers for key components such as biocompatible materials or precision needles have faced increased landed costs, prompting margin compression or price adjustments. In response, several device developers have localized critical production steps to mitigate tariff exposure and secure supply chain resilience. Hospitals and ambulatory centers have felt downstream impacts, negotiating fixed-price contracts to insulate budgets from inflationary pressures. Meanwhile, domestic tooling and microfabrication facilities have expanded capacity to capture repatriated manufacturing volumes. Although short-term headwinds have emerged in the form of inventory realignment and contract renegotiations, the tariff-driven shift has catalyzed strategic supply partnerships and underscored the importance of manufacturing agility. As the market adapts, stakeholders who proactively optimize their procurement footprint and leverage tariff relief programs will gain a competitive edge in cost-effective device delivery.

Key Insights Across Critical Market Segmentation Dimensions

Dissecting the market through distinct segmentation lenses reveals critical growth vectors and unmet needs. When viewed by technology type, the market splits into closure technique, component, material type and thread type. Within closure technique, the modified approach-characterized by integrated anchors or deployable retention systems-is gaining traction over traditional suturing methods due to reduced handling time. Component segmentation shows that demand for precision-engineered needles continues to climb, supplemented by shaft and suture holder innovations that improve maneuverability. Material type differentiation highlights a shift toward biodegradable polymers that offer gradual tensile strength loss, while non-biodegradable fibers retain favor in long-term support scenarios. Thread type segmentation distinguishes non-self-retaining thread devices from self-retaining thread variants that deliver consistent tension without knot tying. Examining procedure-based segmentation, general surgery remains predominant, driven by both abdominal and thoracic interventions. Obstetric applications, especially in caesarean section and hysterectomy closures, are producing robust volumes, while orthopedic arthroscopy and joint replacement procedures underscore precision requirements. Urological closures in kidney and prostatectomy cases are also driving specialized device adaptations. Reviewing end users, ambulatory surgical centers-spanning multispecialty and single specialty facilities-are adopting streamlined devices to maintain high throughput. Hospitals, divided between private and public institutions, are balancing cost pressures with quality imperatives. Scientific research institutes, both private and public, are advancing preclinical assessments, while specialty clinics focused on cosmetic and orthopedic surgery are prioritizing patient comfort and aesthetic outcomes. Additional segmentation by product usability shows single-use devices leading adoption curves in infection control, with reusable options favored in cost-conscious settings. Lastly, age group segmentation indicates that adult patients represent the bulk of procedures, with geriatric cohorts demanding specialized support and pediatric cases requiring miniaturized instrument profiles. Integrating these segmentation insights allows stakeholders to tailor product development, marketing strategies and clinical training programs for maximum impact.

Regional Dynamics Driving Global Market Growth

Geographic performance underscores nuanced regional dynamics. In the Americas, robust reimbursement frameworks and high adoption rates of minimally invasive techniques have positioned this region as a market leader, with significant investments in surgical robotics and enhanced recovery protocols. Europe, Middle East & Africa markets exhibit divergent regulatory landscapes; Western European countries prioritize stringent safety validations and value-based procurement, while emerging EMEA nations focus on improving surgical access through cost-effective device portfolios. In the Asia-Pacific region, escalating healthcare expenditure, expanding hospital networks and a rising incidence of lifestyle-related diseases are fueling accelerated fascial closure device uptake. Government initiatives to bolster domestic manufacturing and public-private partnerships further reinforce growth trajectories across major APAC markets, making this region a key battleground for device innovators seeking scale.

Competitive Landscape and Leading Company Strategies

Competition is intensifying as established medical device powerhouses and specialized innovators vie for market share. Apollo Endosurgery, Inc. continues to expand its portfolio through turret-style closure systems, while BD brings decades of needle and syringe expertise to suture deployment. Boston Scientific Corporation leverages global R&D networks to introduce next-generation anchoring closures, and CONMED Corporation emphasizes streamlined workflows in ambulatory centers. Cook Medical’s deep catalog of biocompatible materials underpins its customizable suture solutions, whereas Ethicon US, LLC (a Johnson & Johnson Company) remains a category leader with integrated surgical platforms. Integra LifeSciences Corporation focuses on tissue regeneration adjuncts, and Lexion Medical, LLC targets proprietary polymer blends for enhanced knot security. Medline Industries, LP integrates supply chain solutions with bundled device offerings. Medtronic PLC, Péters Surgical and Smith & Nephew plc each pursue differentiated strategies in smart suture technology and clinical support services. Stryker Corporation and Teleflex Incorporated amplify their market presence through strategic acquisitions, and W. L. Gore & Associates, Inc. drives innovation in ePTFE-based closure products. Across the competitive landscape, leading players prioritize product differentiation, clinician training, and strategic alliances to accelerate adoption and cement long-term partnerships.

Actionable Recommendations for Industry Leaders

To capitalize on emerging opportunities, industry leaders should adopt a multi-pronged approach. First, intensify investment in early-stage R&D targeting smart materials, automated deployment mechanisms and integrated sensor feedback to deliver measurable clinical advantages. Second, diversify sourcing strategies to mitigate tariff and supply chain risks by establishing hybrid domestic-overseas manufacturing footprints and qualifying alternative raw material suppliers. Third, forge collaborative partnerships with key opinion leaders and surgical societies to generate robust real-world evidence and accelerate guideline inclusion. Fourth, tailor device configurations to distinct clinical segments-offering optimized closures for pediatric, geriatric and high-risk patient groups-while leveraging flexible single-use and reusable platforms. Fifth, pursue strategic alliances or bolt-on acquisitions to fill portfolio gaps, particularly in antimicrobial coatings and digital integration. Finally, invest in comprehensive training and digital simulation programs to enhance surgeon proficiency, driving consistent outcomes and accelerating product adoption.

Conclusion: Charting the Future of Fascial Closure Devices

The evolving fascial closure market demands a blend of innovation, strategic foresight and operational agility. By understanding transformative industry shifts, navigating tariff-related challenges, leveraging segmentation nuances, and partnering with leading device developers, stakeholders can secure competitive advantage. A clear focus on differentiated product development, supply chain resilience and clinician collaboration will be essential in addressing rising procedural volumes and complex patient needs. Ultimately, organizations that execute with precision and align resources around market insights will shape the next frontier of minimally invasive fascial closure technology.

Market Segmentation & Coverage

This research report categorizes the Shield Minimally Invasive Fascial Closure Device Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Closure Technique
    • Modified Technique
    • Standard Technique
  • Component
    • Needle
    • Shaft
    • Suture Holder
  • Material Type
    • Biodegradable Materials
    • Non-Biodegradable Materials
  • Thread Type
    • Non-Self-Retaining Thread
    • Self-Retaining Thread
  • General Surgery
    • Abdominal Surgery
    • Thoracic Surgery
  • Obstetric Surgery
    • Caesarean Section
    • Hysterectomy
  • Orthopedic Surgery
    • Arthroscopy
    • Joint Replacement
  • Urological Surgery
    • Kidney Surgery
    • Prostatectomy
  • Ambulatory Surgical Centers
    • Multispecialty Centers
    • Single Specialty Centers
  • Hospitals
    • Private Hospitals
    • Public Hospitals
  • Scientific Research Institutes
    • Private Research Institutes
    • Public Research Institutes
  • Specialty Clinics
    • Cosmetic Surgery Clinics
    • Orthopedic Clinics
  • Reusable
  • Single-Use
  • Adult
  • Geriatric
  • Pediatric

This research report categorizes the Shield Minimally Invasive Fascial Closure Device Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Shield Minimally Invasive Fascial Closure Device Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Apollo Endosurgery, Inc.
  • BD (Becton, Dickinson and Company)
  • Boston Scientific Corporation
  • CONMED Corporation
  • Cook Medical
  • Ethicon US, LLC (a Johnson & Johnson Company)
  • Integra LifeSciences Corporation
  • Lexion Medical, LLC
  • Medline Industries, LP
  • Medtronic PLC
  • Péters Surgical
  • Smith & Nephew plc
  • Stryker Corporation
  • Teleflex Incorporated
  • W. L. Gore & Associates, Inc.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Shield Minimally Invasive Fascial Closure Device Market, by Technology Type
8.1. Introduction
8.2. Closure Technique
8.2.1. Modified Technique
8.2.2. Standard Technique
8.3. Component
8.3.1. Needle
8.3.2. Shaft
8.3.3. Suture Holder
8.4. Material Type
8.4.1. Biodegradable Materials
8.4.2. Non-Biodegradable Materials
8.5. Thread Type
8.5.1. Non-Self-Retaining Thread
8.5.2. Self-Retaining Thread
9. Shield Minimally Invasive Fascial Closure Device Market, by Procedure
9.1. Introduction
9.2. General Surgery
9.2.1. Abdominal Surgery
9.2.2. Thoracic Surgery
9.3. Obstetric Surgery
9.3.1. Caesarean Section
9.3.2. Hysterectomy
9.4. Orthopedic Surgery
9.4.1. Arthroscopy
9.4.2. Joint Replacement
9.5. Urological Surgery
9.5.1. Kidney Surgery
9.5.2. Prostatectomy
10. Shield Minimally Invasive Fascial Closure Device Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.2.1. Multispecialty Centers
10.2.2. Single Specialty Centers
10.3. Hospitals
10.3.1. Private Hospitals
10.3.2. Public Hospitals
10.4. Scientific Research Institutes
10.4.1. Private Research Institutes
10.4.2. Public Research Institutes
10.5. Specialty Clinics
10.5.1. Cosmetic Surgery Clinics
10.5.2. Orthopedic Clinics
11. Shield Minimally Invasive Fascial Closure Device Market, by Product Usability
11.1. Introduction
11.2. Reusable
11.3. Single-Use
12. Shield Minimally Invasive Fascial Closure Device Market, by Age Group
12.1. Introduction
12.2. Adult
12.3. Geriatric
12.4. Pediatric
13. Americas Shield Minimally Invasive Fascial Closure Device Market
13.1. Introduction
13.2. Argentina
13.3. Brazil
13.4. Canada
13.5. Mexico
13.6. United States
14. Asia-Pacific Shield Minimally Invasive Fascial Closure Device Market
14.1. Introduction
14.2. Australia
14.3. China
14.4. India
14.5. Indonesia
14.6. Japan
14.7. Malaysia
14.8. Philippines
14.9. Singapore
14.10. South Korea
14.11. Taiwan
14.12. Thailand
14.13. Vietnam
15. Europe, Middle East & Africa Shield Minimally Invasive Fascial Closure Device Market
15.1. Introduction
15.2. Denmark
15.3. Egypt
15.4. Finland
15.5. France
15.6. Germany
15.7. Israel
15.8. Italy
15.9. Netherlands
15.10. Nigeria
15.11. Norway
15.12. Poland
15.13. Qatar
15.14. Russia
15.15. Saudi Arabia
15.16. South Africa
15.17. Spain
15.18. Sweden
15.19. Switzerland
15.20. Turkey
15.21. United Arab Emirates
15.22. United Kingdom
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Apollo Endosurgery, Inc.
16.3.2. BD (Becton, Dickinson and Company)
16.3.3. Boston Scientific Corporation
16.3.4. CONMED Corporation
16.3.5. Cook Medical
16.3.6. Ethicon US, LLC (a Johnson & Johnson Company)
16.3.7. Integra LifeSciences Corporation
16.3.8. Lexion Medical, LLC
16.3.9. Medline Industries, LP
16.3.10. Medtronic PLC
16.3.11. Péters Surgical
16.3.12. Smith & Nephew plc
16.3.13. Stryker Corporation
16.3.14. Teleflex Incorporated
16.3.15. W. L. Gore & Associates, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET MULTI-CURRENCY
FIGURE 2. SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET MULTI-LANGUAGE
FIGURE 3. SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY PROCEDURE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY PROCEDURE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY PRODUCT USABILITY, 2024 VS 2030 (%)
FIGURE 14. GLOBAL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY PRODUCT USABILITY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 16. GLOBAL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY CLOSURE TECHNIQUE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY MODIFIED TECHNIQUE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY STANDARD TECHNIQUE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY CLOSURE TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY COMPONENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY NEEDLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY SHAFT, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY SUTURE HOLDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY BIODEGRADABLE MATERIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY NON-BIODEGRADABLE MATERIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY THREAD TYPE, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY NON-SELF-RETAINING THREAD, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY SELF-RETAINING THREAD, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY THREAD TYPE, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY ABDOMINAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY THORACIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY OBSTETRIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY CAESAREAN SECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY HYSTERECTOMY, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY OBSTETRIC SURGERY, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY ARTHROSCOPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY JOINT REPLACEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY UROLOGICAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY KIDNEY SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY PROSTATECTOMY, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY UROLOGICAL SURGERY, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY MULTISPECIALTY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY SINGLE SPECIALTY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY SCIENTIFIC RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY PRIVATE RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY PUBLIC RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY SCIENTIFIC RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY COSMETIC SURGERY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY ORTHOPEDIC CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY PRODUCT USABILITY, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY REUSABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY SINGLE-USE, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY CLOSURE TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY THREAD TYPE, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY OBSTETRIC SURGERY, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY UROLOGICAL SURGERY, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY SCIENTIFIC RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY PRODUCT USABILITY, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 84. ARGENTINA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY CLOSURE TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 86. ARGENTINA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 87. ARGENTINA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY THREAD TYPE, 2018-2030 (USD MILLION)
TABLE 88. ARGENTINA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY OBSTETRIC SURGERY, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY UROLOGICAL SURGERY, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY SCIENTIFIC RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY PRODUCT USABILITY, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 100. BRAZIL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 101. BRAZIL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY CLOSURE TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 102. BRAZIL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 103. BRAZIL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY THREAD TYPE, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY OBSTETRIC SURGERY, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY UROLOGICAL SURGERY, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 113. BRAZIL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY SCIENTIFIC RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 114. BRAZIL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY PRODUCT USABILITY, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 117. CANADA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 118. CANADA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY CLOSURE TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 119. CANADA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 120. CANADA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 121. CANADA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY THREAD TYPE, 2018-2030 (USD MILLION)
TABLE 122. CANADA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 123. CANADA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 124. CANADA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY OBSTETRIC SURGERY, 2018-2030 (USD MILLION)
TABLE 125. CANADA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 126. CANADA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY UROLOGICAL SURGERY, 2018-2030 (USD MILLION)
TABLE 127. CANADA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 128. CANADA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 129. CANADA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 130. CANADA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY SCIENTIFIC RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 131. CANADA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 132. CANADA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY PRODUCT USABILITY, 2018-2030 (USD MILLION)
TABLE 133. CANADA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 134. MEXICO SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 135. MEXICO SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY CLOSURE TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 136. MEXICO SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 137. MEXICO SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 138. MEXICO SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY THREAD TYPE, 2018-2030 (USD MILLION)
TABLE 139. MEXICO SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 140. MEXICO SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 141. MEXICO SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY OBSTETRIC SURGERY, 2018-2030 (USD MILLION)
TABLE 142. MEXICO SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 143. MEXICO SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY UROLOGICAL SURGERY, 2018-2030 (USD MILLION)
TABLE 144. MEXICO SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 145. MEXICO SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 146. MEXICO SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 147. MEXICO SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY SCIENTIFIC RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 148. MEXICO SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 149. MEXICO SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY PRODUCT USABILITY, 2018-2030 (USD MILLION)
TABLE 150. MEXICO SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 151. UNITED STATES SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 152. UNITED STATES SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY CLOSURE TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 153. UNITED STATES SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 154. UNITED STATES SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 155. UNITED STATES SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY THREAD TYPE, 2018-2030 (USD MILLION)
TABLE 156. UNITED STATES SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 157. UNITED STATES SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 158. UNITED STATES SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY OBSTETRIC SURGERY, 2018-2030 (USD MILLION)
TABLE 159. UNITED STATES SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 160. UNITED STATES SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY UROLOGICAL SURGERY, 2018-2030 (USD MILLION)
TABLE 161. UNITED STATES SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 162. UNITED STATES SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 163. UNITED STATES SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 164. UNITED STATES SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY SCIENTIFIC RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 165. UNITED STATES SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 166. UNITED STATES SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY PRODUCT USABILITY, 2018-2030 (USD MILLION)
TABLE 167. UNITED STATES SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 168. UNITED STATES SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 169. ASIA-PACIFIC SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 170. ASIA-PACIFIC SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY CLOSURE TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 171. ASIA-PACIFIC SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 172. ASIA-PACIFIC SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 173. ASIA-PACIFIC SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY THREAD TYPE, 2018-2030 (USD MILLION)
TABLE 174. ASIA-PACIFIC SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 175. ASIA-PACIFIC SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 176. ASIA-PACIFIC SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY OBSTETRIC SURGERY, 2018-2030 (USD MILLION)
TABLE 177. ASIA-PACIFIC SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 178. ASIA-PACIFIC SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY UROLOGICAL SURGERY, 2018-2030 (USD MILLION)
TABLE 179. ASIA-PACIFIC SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 180. ASIA-PACIFIC SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 181. ASIA-PACIFIC SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 182. ASIA-PACIFIC SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY SCIENTIFIC RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 183. ASIA-PACIFIC SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 184. ASIA-PACIFIC SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY PRODUCT USABILITY, 2018-2030 (USD MILLION)
TABLE 185. ASIA-PACIFIC SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 186. ASIA-PACIFIC SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 187. AUSTRALIA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 188. AUSTRALIA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY CLOSURE TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 189. AUSTRALIA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 190. AUSTRALIA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 191. AUSTRALIA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY THREAD TYPE, 2018-2030 (USD MILLION)
TABLE 192. AUSTRALIA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 193. AUSTRALIA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 194. AUSTRALIA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY OBSTETRIC SURGERY, 2018-2030 (USD MILLION)
TABLE 195. AUSTRALIA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 196. AUSTRALIA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY UROLOGICAL SURGERY, 2018-2030 (USD MILLION)
TABLE 197. AUSTRALIA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 198. AUSTRALIA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 199. AUSTRALIA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 200. AUSTRALIA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY SCIENTIFIC RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 201. AUSTRALIA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 202. AUSTRALIA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY PRODUCT USABILITY, 2018-2030 (USD MILLION)
TABLE 203. AUSTRALIA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 204. CHINA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 205. CHINA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY CLOSURE TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 206. CHINA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 207. CHINA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 208. CHINA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY THREAD TYPE, 2018-2030 (USD MILLION)
TABLE 209. CHINA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 210. CHINA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 211. CHINA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY OBSTETRIC SURGERY, 2018-2030 (USD MILLION)
TABLE 212. CHINA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 213. CHINA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY UROLOGICAL SURGERY, 2018-2030 (USD MILLION)
TABLE 214. CHINA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 215. CHINA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 216. CHINA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 217. CHINA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY SCIENTIFIC RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 218. CHINA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 219. CHINA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY PRODUCT USABILITY, 2018-2030 (USD MILLION)
TABLE 220. CHINA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 221. INDIA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 222. INDIA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY CLOSURE TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 223. INDIA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 224. INDIA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 225. INDIA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY THREAD TYPE, 2018-2030 (USD MILLION)
TABLE 226. INDIA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 227. INDIA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 228. INDIA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY OBSTETRIC SURGERY, 2018-2030 (USD MILLION)
TABLE 229. INDIA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 230. INDIA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY UROLOGICAL SURGERY, 2018-2030 (USD MILLION)
TABLE 231. INDIA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 232. INDIA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 233. INDIA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 234. INDIA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY SCIENTIFIC RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 235. INDIA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 236. INDIA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY PRODUCT USABILITY, 2018-2030 (USD MILLION)
TABLE 237. INDIA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 238. INDONESIA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 239. INDONESIA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY CLOSURE TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 240. INDONESIA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 241. INDONESIA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 242. INDONESIA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY THREAD TYPE, 2018-2030 (USD MILLION)
TABLE 243. INDONESIA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 244. INDONESIA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 245. INDONESIA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY OBSTETRIC SURGERY, 2018-2030 (USD MILLION)
TABLE 246. INDONESIA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 247. INDONESIA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY UROLOGICAL SURGERY, 2018-2030 (USD MILLION)
TABLE 248. INDONESIA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 249. INDONESIA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 250. INDONESIA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 251. INDONESIA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY SCIENTIFIC RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 252. INDONESIA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 253. INDONESIA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY PRODUCT USABILITY, 2018-2030 (USD MILLION)
TABLE 254. INDONESIA SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 255. JAPAN SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 256. JAPAN SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY CLOSURE TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 257. JAPAN SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 258. JAPAN SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 259. JAPAN SHIELD MINIMALLY INVASIVE FASCIAL CLOSURE DEVICE MARKET SIZE, BY THREAD TYPE, 2

Companies Mentioned

  • Apollo Endosurgery, Inc.
  • BD (Becton, Dickinson and Company)
  • Boston Scientific Corporation
  • CONMED Corporation
  • Cook Medical
  • Ethicon US, LLC (a Johnson & Johnson Company)
  • Integra LifeSciences Corporation
  • Lexion Medical, LLC
  • Medline Industries, LP
  • Medtronic PLC
  • Péters Surgical
  • Smith & Nephew plc
  • Stryker Corporation
  • Teleflex Incorporated
  • W. L. Gore & Associates, Inc.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Self-Retaining Surgical Retractors Market - Global Forecast to 2030 - Product Image

Self-Retaining Surgical Retractors Market - Global Forecast to 2030

  • Report
  • 190 Pages
  • Global, United States Global, United States
From
Endoscopic Closure Devices Market by Product, End-user - Global Forecast 2025-2030 - Product Image

Endoscopic Closure Devices Market by Product, End-user - Global Forecast 2025-2030

  • Report
  • 183 Pages
  • Global
From
Endoluminal Suturing Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

Endoluminal Suturing Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 185 Pages
  • Global
From
Wound Closure Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Wound Closure Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Structural Heart Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

Structural Heart Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 180 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.